Home > > > > Report Detail

Global Human Vaccine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Publisher Name :
Date: 11-Jan-2019
No. of pages: 116

According to the Centers for Disease Control and Prevention (CDC), a vaccine is a product that stimulates a person's immune system to produce immunity to a specific disease, protecting the person from that disease. Vaccines are usually administered through needle injections, but can also be administered by mouth or sprayed into the nose.

Scope of the Report:

This report focuses on the Human Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

A major trend being witnessed in the global human vaccines market is the increase in strategic alliances. Increase in threat from regional vendors in developing countries may cause price erosion and may compel major players to operate under low-margin models. M&A are usually intended to increase the market penetration of the acquirer or to enhance the product portfolio of the parent company.

The growth of the global human vaccines market is driven by the inclusion of several pediatric vaccines in the national immunization schedule of various countries. This helps in increasing the consumption of vaccines. Similarly, the increase in the prevalence of infectious diseases and cancers is also leading to market growth.

The worldwide market for Human Vaccine is expected to grow at a CAGR of roughly 9.8% over the next five years, will reach 24600 million US$ in 2023, from 14100 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- GlaxoSmithKline

- Merck

- Pfizer

- Sanofi

- AstraZeneca

- Bavarian Nordic

- Baxter

- Bharat Biotech

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- Conjugate

- Recombinant

- Inactivated

- Combination

- Attenuated

- Others

Market Segment by Applications, can be divided into

- Pediatrics

- Adolescents

- Adults

- Geriatrics

There are 15 Chapters to deeply display the global Human Vaccine market.

Chapter 1, to describe Human Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Human Vaccine, with sales, revenue, and price of Human Vaccine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Human Vaccine, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Human Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Human Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Human Vaccine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Human Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Conjugate
1.2.2 Recombinant
1.2.3 Inactivated
1.2.4 Combination
1.2.5 Attenuated
1.2.6 Others
1.3 Market Analysis by Applications
1.3.1 Pediatrics
1.3.2 Adolescents
1.3.3 Adults
1.3.4 Geriatrics
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 Business Overview
2.1.2 Human Vaccine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 GlaxoSmithKline Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck
2.2.1 Business Overview
2.2.2 Human Vaccine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Human Vaccine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi
2.4.1 Business Overview
2.4.2 Human Vaccine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 AstraZeneca
2.5.1 Business Overview
2.5.2 Human Vaccine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AstraZeneca Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bavarian Nordic
2.6.1 Business Overview
2.6.2 Human Vaccine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bavarian Nordic Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Baxter
2.7.1 Business Overview
2.7.2 Human Vaccine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Baxter Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Bharat Biotech
2.8.1 Business Overview
2.8.2 Human Vaccine Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bharat Biotech Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Human Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Human Vaccine Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Human Vaccine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Human Vaccine Manufacturer Market Share in 2017
3.3.2 Top 6 Human Vaccine Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Human Vaccine Market Analysis by Regions
4.1 Global Human Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Human Vaccine Sales and Market Share by Regions (2013-2018)
4.1.2 Global Human Vaccine Revenue and Market Share by Regions (2013-2018)
4.2 North America Human Vaccine Sales and Growth Rate (2013-2018)
4.3 Europe Human Vaccine Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Human Vaccine Sales and Growth Rate (2013-2018)
4.5 South America Human Vaccine Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Human Vaccine Sales and Growth Rate (2013-2018)
5 North America Human Vaccine by Countries
5.1 North America Human Vaccine Sales, Revenue and Market Share by Countries
5.1.1 North America Human Vaccine Sales and Market Share by Countries (2013-2018)
5.1.2 North America Human Vaccine Revenue and Market Share by Countries (2013-2018)
5.2 United States Human Vaccine Sales and Growth Rate (2013-2018)
5.3 Canada Human Vaccine Sales and Growth Rate (2013-2018)
5.4 Mexico Human Vaccine Sales and Growth Rate (2013-2018)
6 Europe Human Vaccine by Countries
6.1 Europe Human Vaccine Sales, Revenue and Market Share by Countries
6.1.1 Europe Human Vaccine Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Human Vaccine Revenue and Market Share by Countries (2013-2018)
6.2 Germany Human Vaccine Sales and Growth Rate (2013-2018)
6.3 UK Human Vaccine Sales and Growth Rate (2013-2018)
6.4 France Human Vaccine Sales and Growth Rate (2013-2018)
6.5 Russia Human Vaccine Sales and Growth Rate (2013-2018)
6.6 Italy Human Vaccine Sales and Growth Rate (2013-2018)
7 Asia-Pacific Human Vaccine by Countries
7.1 Asia-Pacific Human Vaccine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Human Vaccine Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Human Vaccine Revenue and Market Share by Countries (2013-2018)
7.2 China Human Vaccine Sales and Growth Rate (2013-2018)
7.3 Japan Human Vaccine Sales and Growth Rate (2013-2018)
7.4 Korea Human Vaccine Sales and Growth Rate (2013-2018)
7.5 India Human Vaccine Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Human Vaccine Sales and Growth Rate (2013-2018)
8 South America Human Vaccine by Countries
8.1 South America Human Vaccine Sales, Revenue and Market Share by Countries
8.1.1 South America Human Vaccine Sales and Market Share by Countries (2013-2018)
8.1.2 South America Human Vaccine Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Human Vaccine Sales and Growth Rate (2013-2018)
8.3 Argentina Human Vaccine Sales and Growth Rate (2013-2018)
8.4 Colombia Human Vaccine Sales and Growth Rate (2013-2018)
9 Middle East and Africa Human Vaccine by Countries
9.1 Middle East and Africa Human Vaccine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Human Vaccine Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Human Vaccine Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Human Vaccine Sales and Growth Rate (2013-2018)
9.3 UAE Human Vaccine Sales and Growth Rate (2013-2018)
9.4 Egypt Human Vaccine Sales and Growth Rate (2013-2018)
9.5 Nigeria Human Vaccine Sales and Growth Rate (2013-2018)
9.6 South Africa Human Vaccine Sales and Growth Rate (2013-2018)
10 Global Human Vaccine Market Segment by Type
10.1 Global Human Vaccine Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Human Vaccine Sales and Market Share by Type (2013-2018)
10.1.2 Global Human Vaccine Revenue and Market Share by Type (2013-2018)
10.2 Conjugate Sales Growth and Price
10.2.1 Global Conjugate Sales Growth (2013-2018)
10.2.2 Global Conjugate Price (2013-2018)
10.3 Recombinant Sales Growth and Price
10.3.1 Global Recombinant Sales Growth (2013-2018)
10.3.2 Global Recombinant Price (2013-2018)
10.4 Inactivated Sales Growth and Price
10.4.1 Global Inactivated Sales Growth (2013-2018)
10.4.2 Global Inactivated Price (2013-2018)
10.5 Combination Sales Growth and Price
10.5.1 Global Combination Sales Growth (2013-2018)
10.5.2 Global Combination Price (2013-2018)
10.6 Attenuated Sales Growth and Price
10.6.1 Global Attenuated Sales Growth (2013-2018)
10.6.2 Global Attenuated Price (2013-2018)
10.7 Others Sales Growth and Price
10.7.1 Global Others Sales Growth (2013-2018)
10.7.2 Global Others Price (2013-2018)
11 Global Human Vaccine Market Segment by Application
11.1 Global Human Vaccine Sales Market Share by Application (2013-2018)
11.2 Pediatrics Sales Growth (2013-2018)
11.3 Adolescents Sales Growth (2013-2018)
11.4 Adults Sales Growth (2013-2018)
11.5 Geriatrics Sales Growth (2013-2018)
12 Human Vaccine Market Forecast (2018-2023)
12.1 Global Human Vaccine Sales, Revenue and Growth Rate (2018-2023)
12.2 Human Vaccine Market Forecast by Regions (2018-2023)
12.2.1 North America Human Vaccine Market Forecast (2018-2023)
12.2.2 Europe Human Vaccine Market Forecast (2018-2023)
12.2.3 Asia-Pacific Human Vaccine Market Forecast (2018-2023)
12.2.4 South America Human Vaccine Market Forecast (2018-2023)
12.2.5 Middle East and Africa Human Vaccine Market Forecast (2018-2023)
12.3 Human Vaccine Market Forecast by Type (2018-2023)
12.3.1 Global Human Vaccine Sales Forecast by Type (2018-2023)
12.3.2 Global Human Vaccine Market Share Forecast by Type (2018-2023)
12.4 Human Vaccine Market Forecast by Application (2018-2023)
12.4.1 Global Human Vaccine Sales Forecast by Application (2018-2023)
12.4.2 Global Human Vaccine Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Human Vaccine Picture
Table Product Specifications of Human Vaccine
Figure Global Sales Market Share of Human Vaccine by Types in 2017
Table Human Vaccine Types for Major Manufacturers
Figure Conjugate Picture
Figure Recombinant Picture
Figure Inactivated Picture
Figure Combination Picture
Figure Attenuated Picture
Figure Others Picture
Figure Human Vaccine Sales Market Share by Applications in 2017
Figure Pediatrics Picture
Figure Adolescents Picture
Figure Adults Picture
Figure Geriatrics Picture
Figure United States Human Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Human Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Human Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Human Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure France Human Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure UK Human Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Human Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Human Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure China Human Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Human Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Human Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure India Human Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Human Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Human Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Human Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Human Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Human Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Human Vaccine Revenue (Value) and Growth Rate (2013-2023)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Human Vaccine Type and Applications
Table GlaxoSmithKline Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Human Vaccine Type and Applications
Table Merck Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Human Vaccine Type and Applications
Table Pfizer Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Human Vaccine Type and Applications
Table Sanofi Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Human Vaccine Type and Applications
Table AstraZeneca Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table Bavarian Nordic Human Vaccine Type and Applications
Table Bavarian Nordic Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Baxter Basic Information, Manufacturing Base and Competitors
Table Baxter Human Vaccine Type and Applications
Table Baxter Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table Bharat Biotech Human Vaccine Type and Applications
Table Bharat Biotech Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Human Vaccine Sales by Manufacturer (2016-2017)
Figure Global Human Vaccine Sales Market Share by Manufacturer in 2016
Figure Global Human Vaccine Sales Market Share by Manufacturer in 2017
Table Global Human Vaccine Revenue by Manufacturer (2016-2017)
Figure Global Human Vaccine Revenue Market Share by Manufacturer in 2016
Figure Global Human Vaccine Revenue Market Share by Manufacturer in 2017
Figure Top 3 Human Vaccine Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Human Vaccine Manufacturer (Revenue) Market Share in 2017
Figure Global Human Vaccine Sales and Growth Rate (2013-2018)
Figure Global Human Vaccine Revenue and Growth Rate (2013-2018)
Table Global Human Vaccine Sales by Regions (2013-2018)
Table Global Human Vaccine Sales Market Share by Regions (2013-2018)
Table Global Human Vaccine Revenue by Regions (2013-2018)
Figure Global Human Vaccine Revenue Market Share by Regions in 2013
Figure Global Human Vaccine Revenue Market Share by Regions in 2017
Figure North America Human Vaccine Sales and Growth Rate (2013-2018)
Figure Europe Human Vaccine Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Human Vaccine Sales and Growth Rate (2013-2018)
Figure South America Human Vaccine Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Human Vaccine Sales and Growth Rate (2013-2018)
Figure North America Human Vaccine Revenue and Growth Rate (2013-2018)
Table North America Human Vaccine Sales by Countries (2013-2018)
Table North America Human Vaccine Sales Market Share by Countries (2013-2018)
Figure North America Human Vaccine Sales Market Share by Countries in 2013
Figure North America Human Vaccine Sales Market Share by Countries in 2017
Table North America Human Vaccine Revenue by Countries (2013-2018)
Table North America Human Vaccine Revenue Market Share by Countries (2013-2018)
Figure North America Human Vaccine Revenue Market Share by Countries in 2013
Figure North America Human Vaccine Revenue Market Share by Countries in 2017
Figure United States Human Vaccine Sales and Growth Rate (2013-2018)
Figure Canada Human Vaccine Sales and Growth Rate (2013-2018)
Figure Mexico Human Vaccine Sales and Growth Rate (2013-2018)
Figure Europe Human Vaccine Revenue and Growth Rate (2013-2018)
Table Europe Human Vaccine Sales by Countries (2013-2018)
Table Europe Human Vaccine Sales Market Share by Countries (2013-2018)
Table Europe Human Vaccine Revenue by Countries (2013-2018)
Figure Europe Human Vaccine Revenue Market Share by Countries in 2016
Figure Europe Human Vaccine Revenue Market Share by Countries in 2017
Figure Germany Human Vaccine Sales and Growth Rate (2013-2018)
Figure UK Human Vaccine Sales and Growth Rate (2013-2018)
Figure France Human Vaccine Sales and Growth Rate (2013-2018)
Figure Russia Human Vaccine Sales and Growth Rate (2013-2018)
Figure Italy Human Vaccine Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Human Vaccine Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Human Vaccine Sales by Countries (2013-2018)
Table Asia-Pacific Human Vaccine Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Human Vaccine Sales Market Share by Countries 2017
Table Asia-Pacific Human Vaccine Revenue by Countries (2013-2018)
Figure Asia-Pacific Human Vaccine Revenue Market Share by Countries 2017
Figure China Human Vaccine Sales and Growth Rate (2013-2018)
Figure Japan Human Vaccine Sales and Growth Rate (2013-2018)
Figure Korea Human Vaccine Sales and Growth Rate (2013-2018)
Figure India Human Vaccine Sales and Growth Rate (2013-2018)
Figure Southeast Asia Human Vaccine Sales and Growth Rate (2013-2018)
Figure South America Human Vaccine Revenue and Growth Rate (2013-2018)
Table South America Human Vaccine Sales by Countries (2013-2018)
Table South America Human Vaccine Sales Market Share by Countries (2013-2018)
Figure South America Human Vaccine Sales Market Share by Countries in 2017
Table South America Human Vaccine Revenue by Countries (2013-2018)
Table South America Human Vaccine Revenue Market Share by Countries (2013-2018)
Figure South America Human Vaccine Revenue Market Share by Countries in 2017
Figure Brazil Human Vaccine Sales and Growth Rate (2013-2018)
Figure Argentina Human Vaccine Sales and Growth Rate (2013-2018)
Figure Colombia Human Vaccine Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Human Vaccine Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Human Vaccine Sales by Countries (2013-2018)
Table Middle East and Africa Human Vaccine Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Human Vaccine Sales Market Share by Countries in 2017
Table Middle East and Africa Human Vaccine Revenue by Countries (2013-2018)
Table Middle East and Africa Human Vaccine Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Human Vaccine Revenue Market Share by Countries in 2013
Figure Middle East and Africa Human Vaccine Revenue Market Share by Countries in 2017
Figure Saudi Arabia Human Vaccine Sales and Growth Rate (2013-2018)
Figure UAE Human Vaccine Sales and Growth Rate (2013-2018)
Figure Egypt Human Vaccine Sales and Growth Rate (2013-2018)
Figure Nigeria Human Vaccine Sales and Growth Rate (2013-2018)
Figure South Africa Human Vaccine Sales and Growth Rate (2013-2018)
Table Global Human Vaccine Sales by Type (2013-2018)
Table Global Human Vaccine Sales Share by Type (2013-2018)
Table Global Human Vaccine Revenue by Type (2013-2018)
Table Global Human Vaccine Revenue Share by Type (2013-2018)
Figure Global Conjugate Sales Growth (2013-2018)
Figure Global Conjugate Price (2013-2018)
Figure Global Recombinant Sales Growth (2013-2018)
Figure Global Recombinant Price (2013-2018)
Figure Global Inactivated Sales Growth (2013-2018)
Figure Global Inactivated Price (2013-2018)
Figure Global Combination Sales Growth (2013-2018)
Figure Global Combination Price (2013-2018)
Figure Global Attenuated Sales Growth (2013-2018)
Figure Global Attenuated Price (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Others Price (2013-2018)
Table Global Human Vaccine Sales by Application (2013-2018)
Table Global Human Vaccine Sales Share by Application (2013-2018)
Figure Global Adolescents Sales Growth (2013-2018)
Figure Global Adults Sales Growth (2013-2018)
Figure Global Geriatrics Sales Growth (2013-2018)
Figure Global Human Vaccine Sales, Revenue and Growth Rate (2018-2023)
Table Global Human Vaccine Sales Forecast by Regions (2018-2023)
Table Global Human Vaccine Market Share Forecast by Regions (2018-2023)
Figure North America Sales Human Vaccine Market Forecast (2018-2023)
Figure Europe Sales Human Vaccine Market Forecast (2018-2023)
Figure Asia-Pacific Sales Human Vaccine Market Forecast (2018-2023)
Figure South America Sales Human Vaccine Market Forecast (2018-2023)
Figure Middle East and Africa Sales Human Vaccine Market Forecast (2018-2023)
Table Global Human Vaccine Sales Forecast by Type (2018-2023)
Table Global Human Vaccine Market Share Forecast by Type (2018-2023)
Table Global Human Vaccine Sales Forecast by Application (2018-2023)
Table Global Human Vaccine Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs